![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, January 18, 2013 7:35:12 AM
Celsion has literally put all of their eggs in one basket. I believe this to be the most important part of everyone's dd on this company. Personally, I believe in the science. I have had first hand experience with RFA and Liver tumors and understand what the medical process is about. I would be very surprised if Tdox did not far out perform RFA alone. However, if anyone would have any idea what the results were going to be, the company would. It's a blinded study yes....but the side effects from the Tdox arm would surely be a giveaway. CLSN was at $2 and below for a very long time. It would have been easy and prudent for them to raise a ton of cash at the $4 to $5 range. But they did not?
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM